European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Cite this article
Sentinel lymph node detection by intranipple injection of patent blue dye in breast cancer: a preliminary report of a feasibility study
S. Zervoudis1,2,3,*, G. Iatrakis2, M. Paschopoulos3, V. Dousias3, N. Geahchan4, T. Stefos3, F. Pechlivani2, I. Navrozoglou3
1 Breast Unit, Lito and Rea Maternity Hospital, Athens
2 Technological Educational Institution of Athens, Athens
3 Breast Unit, Department of Obstetrics and Gynecology, Medical School, University of Ioannina, Ioannina (Greece)
4 Department of Surgery, Medical School, Saint-Joseph University, Beirut (Lebanon)
Eur. J. Gynaecol. Oncol. 2012, 33(3), 304–305;
Published: 10 June 2012
Sentinel lymph node (SLN) biopsy is a well established option for assessing axillary lymph node status in breast cancer. Several techniques have been applied so far (superficial or deeper ones). Based on anatomical features of the lymphatic drainage in the breast, we assessed the feasibility of an intranipple approach for SLN mapping. Our data support the feasibility of SLN detection by our technique, with a high rate of SLN identification, which could be used in clinical practice as an alternative to the peri-areolar approach.
Sentinel lymph node detection
Techniques for SNL identification